We are live on ! Find out more
UBV

United Bank (Virginia) Portfolio holdings

AUM $853M
1-Year Est. Return 34.07%
This Fund
S&P 500
This Quarter Est. Return
+9.88%
1 Year Est. Return
+34.07%
3 Year Est. Return
+76.1%
5 Year Est. Return
+99.67%
10 Year Est. Return
+313.94%
AUM
$797M
AUM Growth
+$35.4M
Cap. Flow
-$30.6M
Cap. Flow %
-3.84%
Top 10 Hldgs %
44.8%
Holding
154
New
8
Increased
20
Reduced
59
Closed
6

Sector Composition

Rank Sector Weight
1 Industrials 22.33%
2 Technology 16.43%
3 Healthcare 10.15%
4 Financials 10%
5 Energy 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
126
Philip Morris
PM
$290B
$270K 0.03%
2,871
NFLX icon
127
Netflix
NFLX
$309B
$264K 0.03%
5,430
GPC icon
128
Genuine Parts
GPC
$18.5B
$260K 0.03%
1,879
-22
-1% -$3.02K
XYL icon
129
Xylem
XYL
$28.5B
$252K 0.03%
2,200
EPAM icon
130
EPAM Systems
EPAM
$5.17B
$250K 0.03%
840
-235
-22% -$59.7K
NSC icon
131
Norfolk Southern
NSC
$75.3B
$235K 0.03%
+994
New +$208K
TJX icon
132
TJX Companies
TJX
$169B
$230K 0.03%
2,450
FWONK icon
133
Liberty Media Series C
FWONK
$26B
$224K 0.03%
3,550
ZBH icon
134
Zimmer Biomet
ZBH
$18.7B
$224K 0.03%
1,838
QCOM icon
135
Qualcomm
QCOM
$171B
$222K 0.03%
+1,533
New +$190K
RTX icon
136
RTX Corp
RTX
$300B
$218K 0.03%
2,594
-939
-27% -$74.3K
VIG icon
137
Vanguard Dividend Appreciation ETF
VIG
$115B
$215K 0.03%
+1,262
New +$203K
MS icon
138
Morgan Stanley
MS
$342B
$209K 0.03%
+2,242
New +$179K
LIN icon
139
Linde
LIN
$221B
$208K 0.03%
507
-153
-23% -$60.3K
AUTL
140
Autolus Therapeutics
AUTL
$564M
$74.1K 0.01%
11,500
TRVI icon
141
Trevi Therapeutics
TRVI
$2.53B
$38.1K ﹤0.01%
28,450
IRD
142
Opus Genetics
IRD
$313M
$35.5K ﹤0.01%
11,800
LCTX icon
143
Lineage Cell Therapeutics
LCTX
$278M
$32.5K ﹤0.01%
29,800
VOR icon
144
Vor Biopharma
VOR
$1.21B
$24.5K ﹤0.01%
+545
New +$22.5K
CRDF icon
145
Cardiff Oncology
CRDF
$77.1M
$19.2K ﹤0.01%
+13,000
New +$15.7K
AREC icon
146
American Resources Corp
AREC
$300M
$14.9K ﹤0.01%
10,000
VIRX
147
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$14.4K ﹤0.01%
25,200
+5,200
+26% +$3.19K
ACWX icon
148
iShares MSCI ACWI ex US ETF
ACWX
$12B
-16,920
Closed -$795K
AXP icon
149
American Express
AXP
$232B
-1,505
Closed -$225K
CVS icon
150
CVS Health
CVS
$121B
-2,895
Closed -$202K

Similar funds

United Bank (Virginia)'s Q4 2023 Portfolio in Review

As of Q4 2023, United Bank (Virginia) held 154 positions worth $797M, up 4.6% from $761M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

United Bank (Virginia) withdrew a net $30.6M in Q4 2023, closing 6 positions and reducing 59 holdings. Its most notable exit was Vanguard FTSE Emerging Markets ETF, an estimated $2.37M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, down from 24% a quarter earlier, followed by Technology and Healthcare.

Against the trend, United Bank (Virginia) opened a new position in iShares MSCI Emerging Markets ex China ETF worth $33.4M.

  • United Bank (Virginia)'s largest Q4 2023 buy was iShares MSCI Emerging Markets ex China ETF: 602,155 shares worth $33.4M.
  • United Bank (Virginia) added most to Apple in Q4 2023, an estimated $4.61M increase.
  • United Bank (Virginia)'s biggest Q4 2023 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $31.3M.
  • United Bank (Virginia) fully exited Vanguard FTSE Emerging Markets ETF in Q4 2023, selling an estimated $2.37M.
  • United Bank (Virginia)'s ten largest holdings make up 45% of its $797M portfolio in Q4 2023.
  • United Bank (Virginia) opened 8 new positions and closed 6 in Q4 2023.
  • United Bank (Virginia)'s portfolio value rose 4.6% quarter-over-quarter to $797M.

Based on United Bank (Virginia)'s 13F filing for Q4 2023, filed 7 Feb 2024.